Connection
Andrea Bonetto to Activin Receptors, Type II
This is a "connection" page, showing publications Andrea Bonetto has written about Activin Receptors, Type II.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.334 |
|
|
|
-
Hulmi JJ, Nissinen TA, Penna F, Bonetto A. Targeting the Activin Receptor Signaling to Counteract the Multi-Systemic Complications of Cancer and Its Treatments. Cells. 2021 02 28; 10(3).
Score: 0.675
-
Barreto R, Kitase Y, Matsumoto T, Pin F, Colston KC, Couch KE, O'Connell TM, Couch ME, Bonewald LF, Bonetto A. ACVR2B/Fc counteracts chemotherapy-induced loss of muscle and bone mass. Sci Rep. 2017 10 31; 7(1):14470.
Score: 0.536
-
Barreto R, Waning DL, Gao H, Liu Y, Zimmers TA, Bonetto A. Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1/2 and p38 MAPKs. Oncotarget. 2016 Jul 12; 7(28):43442-43460.
Score: 0.122